Emily Woodworth - Mar 1, 2024 Form 3 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Global Controller and CAO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
3
Date filed
3/5/2024, 04:22 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BSX Common Stock 3.86K Mar 1, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BSX Restricted Stock Units Mar 1, 2024 Common Stock 1.92K Direct F1, F2
holding BSX Restricted Stock Units Mar 1, 2024 Common Stock 1.98K Direct F2, F3, F4
holding BSX Restricted Stock Units Mar 1, 2024 Common Stock 1.27K Direct F2, F5, F6
holding BSX Restricted Stock Units Mar 1, 2024 Common Stock 667 Direct F2, F7, F8
holding BSX Stock Option (Right to Buy) Mar 1, 2024 Common Stock 8.33K $37.50 Direct F9
holding BSX Stock Option (Right to Buy) Mar 1, 2024 Common Stock 7.22K $42.16 Direct F10
holding BSX Stock Option (Right to Buy) Mar 1, 2024 Common Stock 4.24K $44.19 Direct F11
holding BSX Stock Option (Right to Buy) Mar 1, 2024 Common Stock 5.96K $47.28 Direct F12
holding BSX Stock Option (Right to Buy) Mar 1, 2024 Common Stock 5.91K $64.99 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.
F2 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F4 This amount represents the unvested portion of RSUs awarded on February 14, 2023, which will continue to vest in three remaining installments on the anniversary of the date of grant.
F5 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F6 This amount represents the unvested portion of RSUs awarded on February 16, 2022, which will continue to vest in two remaining installments on the anniversary of the date of grant.
F7 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F8 This amount represents the unvested portion of RSUs awarded on February 17, 2021, which will continue to vest in one remaining installment on the anniversary of the date of grant.
F9 Grant to the reporting person of an option to purchase 9,532 shares of common stock vesting in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F10 Grant to the reporting person of an option to purchase 7,218 shares of common stock vesting in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.
F11 Grant to the reporting person of an option to purchase 8,473 shares of common stock vesting in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
F12 Grant to the reporting person of an option to purchase 7,939 shares of common stock vesting in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.
F13 Grant to the reporting person of an option to purchase 5,908 shares of common stock vesting in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

Remarks:

collinspoa.txt